Brief: Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities
06/04/2026 12:16
April 6 (Reuters) - Scinai Immunotherapeutics Ltd 2F5y.F: SCINAI COMPLETES STRATEGIC REORGANIZATION TO ESTABLISH DEDICATED CDMO PLATFORM AND LEAN RESEARCH AND DEVELOPMENT STRUCTURE; OUTLINES 2026 PRIORITIES SCINAI IMMUNOTHERAPEUTICS LTD - TRANSFERS ALL CDMO OPERATIONS INTO SCINAI BIOPHARMA SERVICES LTS AS DEDICATED CDMO SUBSIDIARY Source text: ID:nPn6hkqPa Further company coverage: [2F5y.F] ((Reuters.Briefs@thomsonreuters.com;))